Suppr超能文献

《眼药满意度问卷》(EDSQ)的评分和心理测量学特性,该工具用于评估青光眼治疗的满意度和依从性。

Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment.

机构信息

Mapi Values, Lyon, France.

出版信息

BMC Ophthalmol. 2010 Feb 1;10:1. doi: 10.1186/1471-2415-10-1.

Abstract

BACKGROUND

The objective of this study was to ascertain the scoring and assess the psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), a 43-item Patient-Reported Outcome instrument developed to assess patients' satisfaction and compliance with glaucoma treatment.

METHODS

The EDSQ was administered during an observational, retrospective study to 184 French patients treated for glaucoma. The hypothesized structure, including six dimensions (patient-clinician relationship; patient experience; patient-treatment interaction; apprehension; patient knowledge; travel), was tested by assessing the internal consistency reliability (Cronbach's alpha) and construct-related validity (item convergent and discriminant validity). As unsatisfactory results were demonstrated, another structure was defined using a principal component analysis (PCA) combined with content of items. Psychometric properties of this new structure were assessed. Scores were compared between low, moderate and high compliance profile groups defined using data collected with the Travalert electronic device.

RESULTS

Analyses were performed with the 169 patients who completed at least half of the EDSQ items. The hypothesized structure showed a Cronbach's alpha lower than 0.70 for four dimensions out of six and an overall poor construct-related validity (range of item-scale correlations: 0.00-0.68). The new structure obtained with the PCA included six dimensions: concern about treatment (five items); concern about disease (two items); satisfaction with patient-clinician relationship (five items); positive beliefs (three items); treatment convenience (three items); and self-declared compliance (three items). A score ranging from 0 to 100 was calculated for each dimension, with higher scores indicating more of the attribute referred to in the dimension. Internal consistency reliability was good (Cronbach's alpha greater than 0.70 for five dimensions). The structure offered good construct-related validity (range of item-scale correlations: 0.36-0.82). Ceiling effects of 21% and 49%, were observed for the satisfaction with patient-clinician relationship and self-declared compliance scores. Patients in low compliance profile group reported the lowest score for the satisfaction with patient-clinician relationship, positive beliefs, treatment convenience and self-declared compliance dimensions, and the highest score for the concern about treatment dimension.

CONCLUSIONS

The scoring of the EDSQ was developed and the questionnaire proved to have satisfactory psychometric properties. EDSQ scores showed a promising relationship to compliance profiles. The EDSQ could be used in future studies.

摘要

背景

本研究旨在确定眼滴满意度问卷(EDSQ)的评分并评估其心理测量学特性,该问卷是一种 43 项患者报告的结局(PRO)工具,旨在评估患者对青光眼治疗的满意度和依从性。

方法

在一项观察性、回顾性研究中,对 184 名接受青光眼治疗的法国患者进行了 EDSQ 问卷调查。通过评估内部一致性信度(克朗巴赫 α)和结构相关的有效性(项目聚合和区分有效性),检验了包括六个维度(医患关系;患者体验;患者-治疗互动;焦虑;患者知识;旅行)的假设结构。由于结果不理想,使用主成分分析(PCA)结合项目内容定义了另一种结构。评估了这种新结构的心理测量学特性。使用 Travalert 电子设备收集的数据,将评分与低、中、高依从性特征组进行比较。

结果

对完成至少一半 EDSQ 项目的 169 名患者进行了分析。假设结构的六个维度中有四个维度的克朗巴赫 α 值低于 0.70,整体结构相关有效性较差(项目-量表相关性范围:0.00-0.68)。使用 PCA 获得的新结构包括六个维度:对治疗的关注(五个项目);对疾病的关注(两个项目);对医患关系的满意度(五个项目);积极信念(三个项目);治疗便利性(三个项目);以及自我报告的依从性(三个项目)。为每个维度计算了 0 到 100 分的评分,得分越高表示该维度所指属性越高。内部一致性信度良好(五个维度的克朗巴赫 α 值大于 0.70)。结构具有良好的结构相关有效性(项目-量表相关性范围:0.36-0.82)。对医患关系满意度和自我报告的依从性评分观察到 21%和 49%的天花板效应。低依从性特征组的患者报告了对医患关系、积极信念、治疗便利性和自我报告的依从性维度的满意度最低,对治疗关注维度的满意度最高。

结论

EDSQ 的评分已制定,问卷具有令人满意的心理测量学特性。EDSQ 评分与依从性特征有一定的相关性。EDSQ 可用于未来的研究。

相似文献

4
Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).
Health Qual Life Outcomes. 2009 Apr 7;7:30. doi: 10.1186/1477-7525-7-30.
5
Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).
Value Health. 2008 Sep-Oct;11(5):913-26. doi: 10.1111/j.1524-4733.2008.00323.x. Epub 2008 May 20.
10
Psychometric properties of the Greek Diabetes Treatment Satisfaction Questionnaire.
Health Qual Life Outcomes. 2012 Feb 1;10:17. doi: 10.1186/1477-7525-10-17.

引用本文的文献

1
Risk factors for age-related macular degeneration: Updated systematic review and meta-analysis.
Medicine (Baltimore). 2025 Feb 21;104(8):e41599. doi: 10.1097/MD.0000000000041599.
4
Structural validity of the impact of vision impairment questionnaire among patients with visual impairment in Thailand.
Heliyon. 2024 Aug 18;10(16):e36353. doi: 10.1016/j.heliyon.2024.e36353. eCollection 2024 Aug 30.
9
Development of an Item Bank to Measure Medication Adherence: Systematic Review.
J Med Internet Res. 2020 Oct 8;22(10):e19089. doi: 10.2196/19089.
10
Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes.
Patient Prefer Adherence. 2019 Aug 12;13:431-439. doi: 10.2147/PPA.S176412. eCollection 2019.

本文引用的文献

1
Adherence and persistence with glaucoma therapy.
Surv Ophthalmol. 2008 Nov;53 Suppl1:S57-68. doi: 10.1016/j.survophthal.2008.08.002.
3
Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
Ophthalmology. 2008 Aug;115(8):1320-7, 1327.e1-3. doi: 10.1016/j.ophtha.2007.11.023. Epub 2008 Mar 5.
6
The number of people with glaucoma worldwide in 2010 and 2020.
Br J Ophthalmol. 2006 Mar;90(3):262-7. doi: 10.1136/bjo.2005.081224.
7
Patient-reported behavior and problems in using glaucoma medications.
Ophthalmology. 2006 Mar;113(3):431-6. doi: 10.1016/j.ophtha.2005.10.034. Epub 2006 Feb 3.
8
Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops.
J Glaucoma. 2006 Feb;15(1):30-4. doi: 10.1097/01.ijg.0000196654.77836.61.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验